Use of genetic instability to predict biochemical recurrence in intermediate-risk prostate cancer

被引:0
|
作者
Bristow, R. G.
Ishkanian, A. S.
Malloff, C.
Milosevic, M.
Pintilie, M.
van der Kwast, T.
Lam, W.
机构
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada
[4] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
关键词
D O I
10.1200/jco.2011.29.7_suppl.42
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
42
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Improving the Stratification of Patients With Intermediate-risk Prostate Cancer
    Stolzenbach, Lara Franziska
    Nocera, Luigi
    Colla-Ruvolo, Claudia
    Tian, Zhe
    Knipper, Sophie
    Maurer, Tobias
    Tilki, Derya
    Graefen, Markus
    Karakiewicz, Pierre I.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (02) : E120 - E128
  • [32] Radiation treatment for patients with intermediate-risk prostate cancer
    Greene, David E.
    Mayadev, Jyoti S.
    Valicenti, Richard K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (03) : 113 - 124
  • [33] Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer
    Zumsteg, Zachary S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (03): : 744 - 746
  • [34] Management of low- and intermediate-risk prostate cancer
    van der Poel, Henk
    Klotz, Laurence
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 905 - 906
  • [35] Management of low- and intermediate-risk prostate cancer
    Henk van der Poel
    Laurence Klotz
    Christian G. Stief
    World Journal of Urology, 2015, 33 : 905 - 906
  • [36] Reoxygenation during radiotherapy in intermediate-risk prostate cancer
    Supiot, Stephane
    Rousseau, Caroline
    Dore, Melanie
    Cheze-Le-Rest, Catherine
    Kandel-Aznar, Christine
    Potiron, Vincent
    Guerif, Stephane
    Paris, Francois
    Ferrer, Ludovic
    Campion, Loic
    Meingan, Philippe
    Delpon, Gregory
    Hatt, Mathieu
    Visvikis, Dimitris
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : 16 - 19
  • [37] Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer
    Moschini, Marco
    Gandaglia, Giorgio
    Suardi, Nazareno
    Fossati, Nicola
    Cucchiara, Vito
    Damiano, Rocco
    Cantiello, Francesco
    Shariat, Shahrokh F.
    Montorsi, Francesco
    Briganti, Alberto
    INTERNATIONAL JOURNAL OF UROLOGY, 2015, 22 (06) : 555 - 561
  • [38] Identification of genes that predict the biochemical recurrence of prostate cancer
    Chu, Jianfeng
    Li, Ning
    Gai, Wentao
    ONCOLOGY LETTERS, 2018, 16 (03) : 3447 - 3452
  • [39] Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
    Butler, Santino S.
    Mahal, Brandon A.
    Lamba, Nayan
    Mossanen, Matthew
    Martin, Neil E.
    Mouw, Kent W.
    Nguyen, Paul L.
    Muralidhar, Vinayak
    CANCER, 2019, 125 (18) : 3164 - 3171
  • [40] Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
    Sherer, Michael, V
    Leonard, Austin J.
    Nelson, Tyler J.
    Guram, Kripa
    De Moraes, Gustavo Rodrigues
    Javier-Desloges, Juan
    Kane, Christopher
    McKay, Rana R.
    Rose, Brent S.
    Bagrodia, Aditya
    EUROPEAN UROLOGY OPEN SCIENCE, 2023, 50 : 61 - 67